Townson Sharon
Chief Scientific Officer · 11 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-06 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 5,600 | $23.25 | $130,197.20 | filing |
| 2026-07-06 | GLUE | Monte Rosa Therapeutics, Inc. | Option exercise | 6,000 | $6.14 | $36,840.00 | filing |
| 2026-07-06 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 400 | $24.13 | $9,652.00 | filing |
| 2026-06-23 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 3,000 | $20.00 | $60,000.00 | filing |
| 2026-06-23 | GLUE | Monte Rosa Therapeutics, Inc. | Option exercise | 3,000 | $6.14 | $18,420.00 | filing |
| 2026-06-17 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 3,000 | $19.00 | $57,000.00 | filing |
| 2026-06-17 | GLUE | Monte Rosa Therapeutics, Inc. | Option exercise | 3,000 | $6.14 | $18,420.00 | filing |
| 2026-05-29 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 6,000 | $19.87 | $119,220.00 | filing |
| 2026-05-29 | GLUE | Monte Rosa Therapeutics, Inc. | Option exercise | 6,000 | $6.14 | $36,840.00 | filing |
| 2026-01-05 | GLUE | Monte Rosa Therapeutics, Inc. | Sale | 3,155 | $15.17 | $47,861.35 | filing |
| 2026-01-02 | GLUE | Monte Rosa Therapeutics, Inc. | Award | 35,000 | — | — | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.